Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection
Authors
Roy Gulick,
Heather RibaudoCecilia Shikuma,
Stephanie Lustgarten,
Kathleen Squires,
William Meyer,
Edward Acosta,
Bruce Schackman,
Christopher Pilcher,
Robert Murphy,
William Maher,
Mallory Witt,
Richard Reichman,
Sally Snyder,
Karin Klingman +13 authors
,
Daniel Kuritzkes Tip Tip